Apex Frozen Foods Limited
Apex Frozen Foods Limited (APEX.BO) Stock Competitors & Peer Comparison
See (APEX.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| APEX.BO | ₹358.20 | +0.00% | 11.8B | 35.61 | ₹10.57 | +0.53% |
| AWL.NS | ₹176.28 | +0.00% | 248.8B | 26.39 | ₹7.28 | N/A |
| GODREJAGRO.BO | ₹573.65 | +0.00% | 113.2B | 25.78 | ₹22.84 | +1.87% |
| GODREJAGRO.NS | ₹573.90 | +0.00% | 113.2B | 25.80 | ₹22.81 | +1.87% |
| AVANTI.BO | ₹433.45 | -1.17% | 75B | 16.51 | ₹26.25 | N/A |
| KSCL.NS | ₹766.35 | +0.00% | 41.9B | 13.81 | ₹58.95 | +1.23% |
| VENKEYS.NS | ₹1,244.50 | +0.00% | 18.4B | 35.94 | ₹36.32 | +0.77% |
| CHAMANSEQ.BO | ₹256.10 | +0.08% | 13.3B | 18.66 | ₹13.73 | N/A |
| ANDREWYU.NS | ₹31.70 | +1.12% | 12.7B | -150.95 | -₹0.21 | N/A |
| APEX.NS | ₹357.85 | +0.00% | 11.8B | 35.60 | ₹10.57 | +0.53% |
Stock Comparison
APEX.BO vs AWL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, AWL.NS has a market cap of 248.8B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while AWL.NS trades at ₹176.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas AWL.NS's P/E ratio is 26.39. In terms of profitability, APEX.BO's ROE is +0.07%, compared to AWL.NS's ROE of +0.10%. Regarding short-term risk, APEX.BO is more volatile compared to AWL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check AWL.NS's competition here
APEX.BO vs GODREJAGRO.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, GODREJAGRO.BO has a market cap of 113.2B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while GODREJAGRO.BO trades at ₹573.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas GODREJAGRO.BO's P/E ratio is 25.78. In terms of profitability, APEX.BO's ROE is +0.07%, compared to GODREJAGRO.BO's ROE of +0.19%. Regarding short-term risk, APEX.BO is more volatile compared to GODREJAGRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check GODREJAGRO.BO's competition here
APEX.BO vs GODREJAGRO.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, GODREJAGRO.NS has a market cap of 113.2B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while GODREJAGRO.NS trades at ₹573.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas GODREJAGRO.NS's P/E ratio is 25.80. In terms of profitability, APEX.BO's ROE is +0.07%, compared to GODREJAGRO.NS's ROE of +0.19%. Regarding short-term risk, APEX.BO is more volatile compared to GODREJAGRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check GODREJAGRO.NS's competition here
APEX.BO vs AVANTI.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, AVANTI.BO has a market cap of 75B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while AVANTI.BO trades at ₹433.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas AVANTI.BO's P/E ratio is 16.51. In terms of profitability, APEX.BO's ROE is +0.07%, compared to AVANTI.BO's ROE of N/A. Regarding short-term risk, APEX.BO is less volatile compared to AVANTI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check AVANTI.BO's competition here
APEX.BO vs KSCL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, KSCL.NS has a market cap of 41.9B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while KSCL.NS trades at ₹766.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas KSCL.NS's P/E ratio is 13.81. In terms of profitability, APEX.BO's ROE is +0.07%, compared to KSCL.NS's ROE of +0.19%. Regarding short-term risk, APEX.BO is more volatile compared to KSCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check KSCL.NS's competition here
APEX.BO vs VENKEYS.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, VENKEYS.NS has a market cap of 18.4B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while VENKEYS.NS trades at ₹1,244.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas VENKEYS.NS's P/E ratio is 35.94. In terms of profitability, APEX.BO's ROE is +0.07%, compared to VENKEYS.NS's ROE of +0.04%. Regarding short-term risk, APEX.BO is less volatile compared to VENKEYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check VENKEYS.NS's competition here
APEX.BO vs CHAMANSEQ.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, CHAMANSEQ.BO has a market cap of 13.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while CHAMANSEQ.BO trades at ₹256.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas CHAMANSEQ.BO's P/E ratio is 18.66. In terms of profitability, APEX.BO's ROE is +0.07%, compared to CHAMANSEQ.BO's ROE of +0.06%. Regarding short-term risk, APEX.BO is more volatile compared to CHAMANSEQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check CHAMANSEQ.BO's competition here
APEX.BO vs ANDREWYU.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, ANDREWYU.NS has a market cap of 12.7B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while ANDREWYU.NS trades at ₹31.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas ANDREWYU.NS's P/E ratio is -150.95. In terms of profitability, APEX.BO's ROE is +0.07%, compared to ANDREWYU.NS's ROE of +0.03%. Regarding short-term risk, APEX.BO is less volatile compared to ANDREWYU.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check ANDREWYU.NS's competition here
APEX.BO vs APEX.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, APEX.NS has a market cap of 11.8B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while APEX.NS trades at ₹357.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas APEX.NS's P/E ratio is 35.60. In terms of profitability, APEX.BO's ROE is +0.07%, compared to APEX.NS's ROE of +0.07%. Regarding short-term risk, APEX.BO and APEX.NS have similar daily volatility (3.45).Check APEX.NS's competition here
APEX.BO vs MAGADHSUGAR.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, MAGADHSUGAR.BO has a market cap of 9.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while MAGADHSUGAR.BO trades at ₹657.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas MAGADHSUGAR.BO's P/E ratio is 12.00. In terms of profitability, APEX.BO's ROE is +0.07%, compared to MAGADHSUGAR.BO's ROE of +0.09%. Regarding short-term risk, APEX.BO is more volatile compared to MAGADHSUGAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check MAGADHSUGAR.BO's competition here
APEX.BO vs ANDREWYU.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, ANDREWYU.BO has a market cap of 9.2B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while ANDREWYU.BO trades at ₹18.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas ANDREWYU.BO's P/E ratio is 89.43. In terms of profitability, APEX.BO's ROE is +0.07%, compared to ANDREWYU.BO's ROE of +0.03%. Regarding short-term risk, APEX.BO is more volatile compared to ANDREWYU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check ANDREWYU.BO's competition here
APEX.BO vs STEL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, STEL.NS has a market cap of 8.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while STEL.NS trades at ₹443.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas STEL.NS's P/E ratio is 27.98. In terms of profitability, APEX.BO's ROE is +0.07%, compared to STEL.NS's ROE of +0.02%. Regarding short-term risk, APEX.BO is less volatile compared to STEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check STEL.NS's competition here
APEX.BO vs STEL.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, STEL.BO has a market cap of 8.2B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while STEL.BO trades at ₹441.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas STEL.BO's P/E ratio is 27.82. In terms of profitability, APEX.BO's ROE is +0.07%, compared to STEL.BO's ROE of +0.02%. Regarding short-term risk, APEX.BO is more volatile compared to STEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check STEL.BO's competition here
APEX.BO vs DBOL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, DBOL.NS has a market cap of 6.6B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while DBOL.NS trades at ₹96.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas DBOL.NS's P/E ratio is 27.78. In terms of profitability, APEX.BO's ROE is +0.07%, compared to DBOL.NS's ROE of +0.02%. Regarding short-term risk, APEX.BO is more volatile compared to DBOL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check DBOL.NS's competition here
APEX.BO vs DBOL.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, DBOL.BO has a market cap of 6.5B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while DBOL.BO trades at ₹96.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas DBOL.BO's P/E ratio is 27.65. In terms of profitability, APEX.BO's ROE is +0.07%, compared to DBOL.BO's ROE of +0.02%. Regarding short-term risk, APEX.BO is more volatile compared to DBOL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check DBOL.BO's competition here
APEX.BO vs MGEL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, MGEL.NS has a market cap of 3.5B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while MGEL.NS trades at ₹10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas MGEL.NS's P/E ratio is 9.20. In terms of profitability, APEX.BO's ROE is +0.07%, compared to MGEL.NS's ROE of +0.18%. Regarding short-term risk, APEX.BO is less volatile compared to MGEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check MGEL.NS's competition here
APEX.BO vs HARRMALAYA.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, HARRMALAYA.BO has a market cap of 3.2B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while HARRMALAYA.BO trades at ₹170.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas HARRMALAYA.BO's P/E ratio is 11.26. In terms of profitability, APEX.BO's ROE is +0.07%, compared to HARRMALAYA.BO's ROE of +0.16%. Regarding short-term risk, APEX.BO is more volatile compared to HARRMALAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check HARRMALAYA.BO's competition here
APEX.BO vs HARRMALAYA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, HARRMALAYA.NS has a market cap of 3.2B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while HARRMALAYA.NS trades at ₹170.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas HARRMALAYA.NS's P/E ratio is 12.77. In terms of profitability, APEX.BO's ROE is +0.07%, compared to HARRMALAYA.NS's ROE of +0.16%. Regarding short-term risk, APEX.BO is more volatile compared to HARRMALAYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check HARRMALAYA.NS's competition here
APEX.BO vs PKTEA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, PKTEA.NS has a market cap of 2.6B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while PKTEA.NS trades at ₹820.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas PKTEA.NS's P/E ratio is -1141.89. In terms of profitability, APEX.BO's ROE is +0.07%, compared to PKTEA.NS's ROE of -0.00%. Regarding short-term risk, APEX.BO is less volatile compared to PKTEA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check PKTEA.NS's competition here
APEX.BO vs UNITEDTEA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, UNITEDTEA.NS has a market cap of 2.6B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while UNITEDTEA.NS trades at ₹510.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas UNITEDTEA.NS's P/E ratio is 11.55. In terms of profitability, APEX.BO's ROE is +0.07%, compared to UNITEDTEA.NS's ROE of +0.10%. Regarding short-term risk, APEX.BO is more volatile compared to UNITEDTEA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check UNITEDTEA.NS's competition here
APEX.BO vs VIKASLIFE.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, VIKASLIFE.BO has a market cap of 2.4B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while VIKASLIFE.BO trades at ₹1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas VIKASLIFE.BO's P/E ratio is -16.12. In terms of profitability, APEX.BO's ROE is +0.07%, compared to VIKASLIFE.BO's ROE of -0.02%. Regarding short-term risk, APEX.BO is less volatile compared to VIKASLIFE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check VIKASLIFE.BO's competition here
APEX.BO vs JAYSREETEA.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, JAYSREETEA.BO has a market cap of 2.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while JAYSREETEA.BO trades at ₹84.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas JAYSREETEA.BO's P/E ratio is 5.69. In terms of profitability, APEX.BO's ROE is +0.07%, compared to JAYSREETEA.BO's ROE of +0.10%. Regarding short-term risk, APEX.BO is less volatile compared to JAYSREETEA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check JAYSREETEA.BO's competition here
APEX.BO vs JAYSREETEA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, JAYSREETEA.NS has a market cap of 2.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while JAYSREETEA.NS trades at ₹84.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas JAYSREETEA.NS's P/E ratio is 5.66. In terms of profitability, APEX.BO's ROE is +0.07%, compared to JAYSREETEA.NS's ROE of +0.10%. Regarding short-term risk, APEX.BO is less volatile compared to JAYSREETEA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check JAYSREETEA.NS's competition here
APEX.BO vs SAKUMA.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, SAKUMA.BO has a market cap of 2.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while SAKUMA.BO trades at ₹1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas SAKUMA.BO's P/E ratio is 20.86. In terms of profitability, APEX.BO's ROE is +0.07%, compared to SAKUMA.BO's ROE of +0.01%. Regarding short-term risk, APEX.BO is more volatile compared to SAKUMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check SAKUMA.BO's competition here
APEX.BO vs SAKUMA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, SAKUMA.NS has a market cap of 2.3B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while SAKUMA.NS trades at ₹1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas SAKUMA.NS's P/E ratio is 36.50. In terms of profitability, APEX.BO's ROE is +0.07%, compared to SAKUMA.NS's ROE of +0.01%. Regarding short-term risk, APEX.BO is more volatile compared to SAKUMA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check SAKUMA.NS's competition here
APEX.BO vs ASPINWALL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, ASPINWALL.NS has a market cap of 1.6B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while ASPINWALL.NS trades at ₹207.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas ASPINWALL.NS's P/E ratio is 17.28. In terms of profitability, APEX.BO's ROE is +0.07%, compared to ASPINWALL.NS's ROE of +0.05%. Regarding short-term risk, APEX.BO is more volatile compared to ASPINWALL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check ASPINWALL.NS's competition here
APEX.BO vs NORBTEAEXP.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, NORBTEAEXP.NS has a market cap of 1.1B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while NORBTEAEXP.NS trades at ₹88.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas NORBTEAEXP.NS's P/E ratio is -160.71. In terms of profitability, APEX.BO's ROE is +0.07%, compared to NORBTEAEXP.NS's ROE of -0.03%. Regarding short-term risk, APEX.BO is less volatile compared to NORBTEAEXP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check NORBTEAEXP.NS's competition here
APEX.BO vs NORBTEAEXP.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, NORBTEAEXP.BO has a market cap of 1.1B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while NORBTEAEXP.BO trades at ₹88.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas NORBTEAEXP.BO's P/E ratio is -157.37. In terms of profitability, APEX.BO's ROE is +0.07%, compared to NORBTEAEXP.BO's ROE of -0.03%. Regarding short-term risk, APEX.BO is more volatile compared to NORBTEAEXP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check NORBTEAEXP.BO's competition here
APEX.BO vs GROBTEA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, GROBTEA.NS has a market cap of 1B. Regarding current trading prices, APEX.BO is priced at ₹358.20, while GROBTEA.NS trades at ₹905.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas GROBTEA.NS's P/E ratio is 18.40. In terms of profitability, APEX.BO's ROE is +0.07%, compared to GROBTEA.NS's ROE of +0.06%. Regarding short-term risk, APEX.BO is less volatile compared to GROBTEA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check GROBTEA.NS's competition here
APEX.BO vs UMAEXPORTS.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, UMAEXPORTS.BO has a market cap of 715.1M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while UMAEXPORTS.BO trades at ₹21.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas UMAEXPORTS.BO's P/E ratio is -14.69. In terms of profitability, APEX.BO's ROE is +0.07%, compared to UMAEXPORTS.BO's ROE of -0.02%. Regarding short-term risk, APEX.BO is less volatile compared to UMAEXPORTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check UMAEXPORTS.BO's competition here
APEX.BO vs UMAEXPORTS.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, UMAEXPORTS.NS has a market cap of 709.7M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while UMAEXPORTS.NS trades at ₹20.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas UMAEXPORTS.NS's P/E ratio is -14.58. In terms of profitability, APEX.BO's ROE is +0.07%, compared to UMAEXPORTS.NS's ROE of -0.02%. Regarding short-term risk, APEX.BO is less volatile compared to UMAEXPORTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check UMAEXPORTS.NS's competition here
APEX.BO vs AGRITECH.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, AGRITECH.NS has a market cap of 624.4M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while AGRITECH.NS trades at ₹106.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas AGRITECH.NS's P/E ratio is -67.38. In terms of profitability, APEX.BO's ROE is +0.07%, compared to AGRITECH.NS's ROE of -0.01%. Regarding short-term risk, APEX.BO is less volatile compared to AGRITECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check AGRITECH.NS's competition here
APEX.BO vs AGRITECH.BO Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, AGRITECH.BO has a market cap of 614.8M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while AGRITECH.BO trades at ₹103.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas AGRITECH.BO's P/E ratio is -66.35. In terms of profitability, APEX.BO's ROE is +0.07%, compared to AGRITECH.BO's ROE of -0.01%. Regarding short-term risk, APEX.BO is less volatile compared to AGRITECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check AGRITECH.BO's competition here
APEX.BO vs DHANLAXMI.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, DHANLAXMI.NS has a market cap of 400M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while DHANLAXMI.NS trades at ₹24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas DHANLAXMI.NS's P/E ratio is 3.74. In terms of profitability, APEX.BO's ROE is +0.07%, compared to DHANLAXMI.NS's ROE of +0.11%. Regarding short-term risk, APEX.BO is less volatile compared to DHANLAXMI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check DHANLAXMI.NS's competition here
APEX.BO vs KGL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, KGL.NS has a market cap of 359.4M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while KGL.NS trades at ₹0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas KGL.NS's P/E ratio is 1.05. In terms of profitability, APEX.BO's ROE is +0.07%, compared to KGL.NS's ROE of -0.67%. Regarding short-term risk, APEX.BO is less volatile compared to KGL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check KGL.NS's competition here
APEX.BO vs SANWARIA.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, SANWARIA.NS has a market cap of 346.8M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while SANWARIA.NS trades at ₹0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas SANWARIA.NS's P/E ratio is -4.17. In terms of profitability, APEX.BO's ROE is +0.07%, compared to SANWARIA.NS's ROE of +0.01%. Regarding short-term risk, APEX.BO is more volatile compared to SANWARIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check SANWARIA.NS's competition here
APEX.BO vs SRPL.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, SRPL.NS has a market cap of 209.9M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while SRPL.NS trades at ₹0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas SRPL.NS's P/E ratio is -0.52. In terms of profitability, APEX.BO's ROE is +0.07%, compared to SRPL.NS's ROE of -0.44%. Regarding short-term risk, APEX.BO is more volatile compared to SRPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APEX.BO.Check SRPL.NS's competition here
APEX.BO vs SHANTI.NS Comparison March 2026
APEX.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APEX.BO stands at 11.8B. In comparison, SHANTI.NS has a market cap of 69.3M. Regarding current trading prices, APEX.BO is priced at ₹358.20, while SHANTI.NS trades at ₹6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APEX.BO currently has a P/E ratio of 35.61, whereas SHANTI.NS's P/E ratio is -2.51. In terms of profitability, APEX.BO's ROE is +0.07%, compared to SHANTI.NS's ROE of +0.16%. Regarding short-term risk, APEX.BO is less volatile compared to SHANTI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APEX.BO.Check SHANTI.NS's competition here